Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of EGP-437 (dexamethasone
phosphate formulated for ocular iontophoresis) using the EyeGate® II Iontophoresis system in
patients with dry eye.